Core Viewpoint - The article discusses the new tariffs imposed by the U.S. on China under the International Emergency Economic Powers Act (IEEPA), highlighting two main components: the "fentanyl tariff" and the "reciprocal tariff" [1] Summary by Relevant Categories Tariff Details - The current tariff rate on China for the "fentanyl tariff" is 10% [1] - The "reciprocal tariff" also has a 10% rate currently enforced, while an additional 24% rate is on hold [1] Legal Context - According to U.S. executive orders, these tariffs are stated to be "terminated as soon as possible" [1] - A ruling from the U.S. Supreme Court implies that any administrative orders to cancel IEEPA tariffs will also apply to the relevant parts of the U.S.-China tariff arrangements, leading to an automatic cancellation of the IEEPA tariffs on China [1]

市场有风险，投资需谨慎。本文不构成个人投资建议，也未考虑到个别用户特殊的投资目标、财务状况或需要。用户应考虑本文中的任何 意见、观点或结论是否符合其特定状况。据此投资，责任自负。 玉渊谭天表示，自去年2月以来，美国依据《国际紧急经济权力法》（IEEPA）对华加征的新关税主要 有两部分。一是所谓的"芬太尼关税"，目前对华税率是10%；二是所谓的"对等关税"，目前对华执行其 中的10%税率，余下24%税率暂缓执行。按照美国行政令的说法，这些援引美国《国际紧急经济权力 法》实施的关税将"尽快终止征收"。在美国最高法院作出裁决后，也就意味着美方根据最高法院判决发 布的取消IEEPA关税的行政命令同样也适用于中美关税安排中的相关部分，对华IEEPA关税应自动取 消。 熟悉国际经贸谈判事务的崔凡表示，如果美方停止相关措施或下调税率，中方不排除会根据实际 变化作出评估和调整的可能性；但如果美方以其他法律工具继续加征新的关税，中方也会研判是否采取 相应措施。 风险提示及免责条款 ...

美国总统特朗普遭遇他第二个任期内最大的法庭败绩，他的核心政策工具被最高法院裁定违法。 据央视新闻，当地时间20日，美国最高法院裁定，特朗普政府依据《国际紧急经济权力法》（IEEPA）实施的相关大规模关税措施缺乏明确法律授权。 最高法院以6票对3票的投票结果裁定，1977年出台的IEEPA并未赋予总统在未经国会批准时征收关税的权力。特朗普援引IEEPA在全球范围内实施所谓"对 等关税"以及针对特定进口商品征收的关税，超出了IEEPA赋予总统的权限。 首席大法官John Roberts在裁决书中写道："IEEPA并未授权总统征收关税。" 此裁决意味着，最高法院维持了下级法院去年作出的特朗普关税越权原判。特 朗普政府目前实行的大部分关税将被迫中止，包括所谓"芬太尼关税"以及去年4月首次宣布的对等关税。 据人民日报，2005年5月，位于纽约的美国国际贸易法院3人合议庭就小企业主和美国12州所提诉讼裁定，总统无权援引IEEPA征收上述关税。8月29日，美 国联邦巡回上诉法院在审理特朗普政府上诉后以7比4的投票结果维持原裁决。 据央视，在美最高法院作出关税政策违法的裁决后，特朗普表示此裁决"可耻"。央视提到，知情人士称， ...

Group 1 - The tariff policy promoted by Trump has revealed significant issues, particularly due to severe malfunctions in the U.S. customs system, leading to a halt in the collection of new tariffs [1][3] - The customs system's failure is not an isolated incident but a culmination of long-standing technical problems, exacerbated by budget cuts and staff shortages, which hinder the effective implementation of tariff policies [3][6] - The disconnect between policy design and execution capabilities indicates that Trump's tariff strategy is more of a political stance than a viable policy solution, with the emphasis on rhetoric over practical implementation [6][10] Group 2 - Legal uncertainties surrounding the tariffs, including questions of legality and potential overreach, have emerged, raising concerns for businesses about the stability of the regulatory environment [8][10] - The challenges faced by U.S. customs in managing the influx of small cross-border packages highlight the inadequacies of the current system, which lacks the necessary resources for effective tariff enforcement [13][15] - Despite the escalating rhetoric surrounding tariffs, the actual execution capabilities are diminishing, revealing vulnerabilities in the U.S. administrative system and the limitations of aggressive trade policies [15][17]

Group 1 - The U.S. Supreme Court is set to announce a ruling on tariffs on January 9, which could significantly impact the Trump administration's economic policies and represent a major legal setback for Trump since taking office [1][2] - If the Supreme Court rules against the Trump administration, it may lead to the potential refund of over $133.5 billion in tariffs collected from importers [1][6] - The tariffs in question were imposed under the International Emergency Economic Powers Act (IEEPA) without Congressional approval, and previous courts have deemed these policies illegal [2][3] Group 2 - The Trump administration has plans to reimpose tariffs if the ruling is unfavorable, potentially utilizing the Trade Expansion Act of 1962 and the Trade Act of 1974 to justify new tariffs [4][5] - Legal experts indicate that the administration could invoke various trade laws to impose tariffs of up to 50% on certain goods, depending on the court's decision [5] - Major retailers and companies, including Costco and Revlon, have initiated lawsuits to reclaim tariffs paid, with approximately 40 legal briefs submitted to the Supreme Court opposing the Trump administration's tariff policies [8]

Core Viewpoint - The U.S. Supreme Court is scheduled to release opinions on January 9, which may include a ruling on the Trump tariffs case, marking a significant potential timeline for the resolution of this legal matter [1][2]. Group 1: Legal Proceedings - The central issue in the case revolves around whether Trump's imposition of "reciprocal tariffs" and "fentanyl tariffs" under the International Emergency Economic Powers Act (IEEPA) is lawful [1]. - The U.S. International Trade Court ruled in May 2022 that the "reciprocal tariffs" exceeded the legal authority of the Trump administration, and the Federal Circuit Court upheld this decision in August 2022 [2]. - The Supreme Court's decision is highly anticipated, especially since the Biden administration has urged for a swift ruling to avoid potential chaos from accumulated tariffs, which could exceed $200 billion by 2025 [2]. Group 2: Political Implications - President Trump has expressed significant concern over the potential negative impact of a ruling against him, stating that a loss would be a "terrible blow" to the U.S. [2]. - The Supreme Court is also handling other significant cases, including one related to redistricting in Louisiana, which could affect the political landscape in the state [2].

Core Viewpoint - The U.S. Supreme Court is scheduled to announce its decision on the Trump tariff case on January 9, which could have significant implications for U.S. trade policy and government revenue [1][3]. Group 1: Case Background - The case revolves around the legality of tariffs imposed by Trump under the International Emergency Economic Powers Act (IEEPA), specifically the "reciprocal tariffs" and "fentanyl tariffs" [3][6]. - The U.S. International Trade Court previously ruled that these tariffs exceeded the legal authority of the Trump administration, and the Federal Circuit Court upheld this ruling [6]. Group 2: Implications of the Ruling - If the Supreme Court rules against the Trump administration, it could lead to significant financial repercussions, with projected tariff revenues exceeding $200 billion by 2025 [6]. - Treasury Secretary Yellen has expressed concerns that a delayed ruling could result in "significant chaos" if the accumulated tariffs are deemed illegal [6]. Group 3: Market Sentiment - Following the oral arguments in November, the prediction market Polymarket indicated a drop in the probability of Trump winning the case to around 20% [3][6]. - Trump himself has voiced concerns about the potential negative impact of a ruling against him, stating it would be a "terrible blow" to the U.S. [6].

Market Performance - A-shares collectively retreated, with the Shanghai Composite Index closing down 0.81% at 3954.79 points, the Shenzhen Component down 1.14%, and the ChiNext Index down 2.31%[1] - The Hong Kong Hang Seng Index fell 1.43% to 25906.65 points, with the Hang Seng Tech Index down 2.37% and the Hang Seng China Enterprises Index down 1.91%[1] - The total market turnover in Hong Kong decreased to 257.613 billion HKD[1] Economic Indicators - In October, the sales revenue of China's top 100 real estate companies dropped by over 41.9% year-on-year, amounting to 253 billion RMB (approximately 35.6 billion USD)[12] - The U.S. stock indices showed slight gains, with the Dow Jones up 0.09%, S&P 500 up 0.26%, and Nasdaq up 0.61%[1] Trade Relations - U.S. President Trump indicated willingness to eliminate all tariffs related to fentanyl if China takes strict measures against its export[12] - The EU is reportedly considering a new trade measure called "physical tariffs" to ensure the supply of critical raw materials from China[12] Sector Performance - Energy and metals sectors showed gains, while pharmaceutical stocks performed strongly against the market trend[1] - The overall decline in the real estate sector reflects ongoing challenges in the Chinese housing market, which has been struggling for over four years[12]

Core Viewpoint - China expresses sympathy for the American people affected by the fentanyl crisis and calls for the U.S. to create necessary conditions for cooperation [1] Group 1: China's Position on Drug Control - China maintains a consistent and clear stance on drug control, being one of the countries with the most stringent regulations and the highest number of controlled substances [1] - The Chinese government has a strong record in drug prohibition and has previously provided assistance to the U.S. regarding the fentanyl issue, achieving positive results [1] Group 2: Call for Cooperation - China is open to continuing cooperation with the U.S. on the fentanyl crisis and urges the U.S. to take practical actions to facilitate this collaboration [1]

Core Points - U.S. companies are urging the Supreme Court to uphold lower court rulings that deemed tariffs imposed by the Trump administration as illegal taxes on American businesses [1][3] - The legal basis for these tariffs, invoked under the International Emergency Economic Powers Act (IEEPA), is being challenged as an overreach of presidential authority [4][5] Group 1: Legal Challenges - Seven companies and several states are contesting the legality of tariffs imposed under IEEPA, claiming they create unprecedented tax burdens [3] - The IEEPA allows the president to take economic control measures during a national emergency, but its application for tariffs is disputed [3][4] - The plaintiffs argue that IEEPA does not grant the president the unilateral power to impose tariffs, as it only allows for actions like freezing foreign assets [4][6] Group 2: Economic Impact - The tariffs are expected to lead to significant financial strain on small businesses, with claims that they could result in bankruptcies and an annual loss of at least $1,000 per average American [5][6] - The unpredictability of tariff changes is disrupting supply chains and harming relationships between businesses and their suppliers and customers [6] - Learning Resources claims that the tariffs could lead to a tax increase of over $3 trillion for American taxpayers over the next decade [6] Group 3: Court Proceedings - The Supreme Court is set to hear the case on November 5, with expectations that it will uphold the lower court's ruling against the legality of the tariffs [2][3] - The plaintiffs' briefs submitted to the court emphasize that tariffs fall under the constitutional authority of Congress, not the president [3][4] - The outcome of the Supreme Court's decision will determine the future of the so-called "reciprocal tariffs" and "fentanyl tariffs" [6][7]